Rau Consulting
Private Company
Funding information not available
Overview
Founded in 2019, Rau Consulting is a private, service-oriented consultancy leveraging deep expertise in bioprocessing and regulatory strategy to support biopharma companies. The firm's core offerings include CMC strategy, cell and gene therapy development support, technology transfer, process development, and Computer Software Assurance (CSA), all aimed at accelerating client projects from development to market. Led by Principal Consultant Dr. Tiffany D. Rau, a Six Sigma Master Black Belt with extensive international experience, the company serves as a strategic partner to bridge R&D and manufacturing. Its model is based on providing tailored consulting and training, positioning it as a revenue-generating entity within the competitive biopharma services landscape.
Technology Platform
Consultancy expertise in bioprocessing, CMC, cell/gene therapy development, technology transfer, and Computer Software Assurance (CSA). Methodology is based on Six Sigma and risk-based, tailored approaches to drug development challenges.
Opportunities
Risk Factors
Competitive Landscape
Rau Consulting competes in the fragmented biopharma consulting market against large global firms (e.g., IQVIA, Parexel), specialized technical boutiques, and independent consultants. Its differentiation lies in its deep, hands-on technical expertise in bioprocessing and CGT, combined with a lean, tailored service model and advocacy for modern frameworks like CSA.